The move follows a green light by the UK’s MHRA

The Institute has endorsed the drug for first-line treatment of adults with locally-advanced or EGFR mutation-positive NSCLC

Updated Date: Fri, 04 Sep 2020 00:00:00 EDT

Updated Date: Fri, 04 Sep 2020 00:00:00 EDT

Updated Date: Fri, 04 Sep 2020 00:00:00 EDT

This living systematic review by Siemieniuk and colleagues (BMJ 2020;370:m2980) has been updated. For the latest update, visit […]

AstraZeneca changes minds at NICE, winning Tagrisso coverage in 2 lung cancer indications aliu Fri, 09/11/2020 – 11:13

Eli Lilly’s Reyvow, squaring off against AbbVie and Biohaven, posts data showing early and lasting migraine relief esagonowsky […]

Pfizer, Novartis and others return to Facebook after hate speech boycott, but plan to keep tabs on changes […]

FDA leaders, facing doubts over the agency’s independence, pledge to ‘follow the science’ amid pandemic esagonowsky Fri, 09/11/2020 […]